Published in Gene Therapy Weekly, February 5th, 1996
Gene therapy strategies for human prostate cancer include: ex vivo manipulation of prostate cancer cells to produce recombinant cytokines; cancer cell vaccines; and correction of known molecular defects in cancer cells. All of these processes involve manipulation of autologous cells from the patient, and can be expensive, time consuming protocols.
It would be anticipated, and has been shown, that cancer cells that have mutant or no endogenous p53 could exhibit growth inhibition if normal p53 function was restored....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly